GALWAY, Ireland, Oct. 22, 2025 /PRNewswire/ -- Neurent Medical, a leader in non-surgical treatments for chronic rhinitis, today announced that UnitedHealthcare's Medicare Advantage policy has removed ...
Effective immediately, CPT 31242 is no longer considered experimental, removing a key barrier for ENT physicians treating chronic rhinitis. GALWAY, Ireland, Oct. 22, 2025 /PRNewswire/ -- Neurent ...
THE WOODLANDS, TX, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (AMIX) (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision ...
About 150,000 people a year are diagnosed with trigeminal neuralgia, according to the American Association of Neurological Surgeons. The pain is caused by irritation of the trigeminal nerve that ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. NeuroOne Medical Technologies ( (NMTC)) ...
EDEN PRAIRIE, Minn., Aug. 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care ...
The Evo sEEG electrodes (left) and RF generator comprise the OneRF system. [Images courtesy of NeuroOne] NeuroOne (Nasdaq:NMTC) announced today that it received FDA clearance for its OneRF trigeminal ...
Neuroone Medical Technologies Corp. expanded into treatment of chronic pain with a new U.S. FDA clearance for use of its Onerf system to treat trigeminal nerve pain. The system uses radiofrequency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback